Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 12 (2), 102-108
- https://doi.org/10.1016/0264-410x(94)90046-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Severe malaria in Gambian children is not due to lack of previous exposure to malariaClinical and Experimental Immunology, 1992
- Comparison of antibody responses to the circumsporozoite protein repeat region and to intact sporozoites during acute falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
- Naturally Acquired Antibodies to Sporozoites Do Not Prevent Malaria: Vaccine Development ImplicationsScience, 1987
- Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.JCI Insight, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINEThe Lancet, 1987
- Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.The Journal of Experimental Medicine, 1983
- Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.The Journal of Experimental Medicine, 1980
- Prepatent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoitesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1976